pSivida opens enrolments for macular edema treatment trials

Perth-based biotechnology company pSivida Ltd has commenced enrolment for the first studies of absorption, distribution and metabolism of its diabetic macular edema treatment Medidur, the company has announced.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer